Letter to the Editor: HBcrAg and Prediction of Hepatocellular Carcinoma Risk.
Marc G GhanyWendy C KingMauricio Lisker-MelmanAnna Sf LokNorah TerraultHarry L A JanssenMandana KhaliliRaymond T ChungWilliam M LeeDaryl T Y LauGavin A ClohertyRichard K SterlingPublished in: Hepatology (Baltimore, Md.) (2021)
We wish to respond to the comments received from Drs. Wu, Tseng and Kao. Our analysis was focused on comparing HBV RNA and hepatitis B core related antigen (HBcrAg) levels with existing markers of hepatitis B virus (HBV) replication (HBV DNA and hepatitis B surface antigen) and whether the two novel markers could improve distinguishing the different phases of infection.